Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|May 1, 1991
Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokersC M Loi, X X Wei, R E VestalJournal of Clinical Pharmacology|September 30, 1998
Effect of troglitazone on urinary excretion of 6beta-hydroxycortisolJ R Koup, G D Anderson, C M LoiClinical Pharmacology and Therapeutics|March 1, 1985
Cigarette smoking and theophylline metabolism: effects of cimetidineB J Cusack, G W Dawson, G D Mercer, et al.The Journal of Allergy and Clinical Immunology|October 1, 1986
Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activationC P Nielson, J J Crowley, B J Cusack, et al.Clinical Pharmacology and Therapeutics|March 1, 1987
Additive effect of theophylline on the cardiac response to isoproterenolB J Cusack, C P Nielson, M E Morgan, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the ratB J Cusack, S P Young, R E Vestal, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 1995
Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activityX Wei, C M Loi, E J Jarvi, et al.Biochemical Pharmacology|May 26, 1995
Characterization of the independent and combined effects of two inhibitors on oxidative drug metabolism in rat liver microsomesX Wei, C M Loi, D L Schmucker, et al.British Journal of Pharmacology|August 26, 2000
Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the ratB E Burke, H Gambliel, R D Olson, et al.Life Sciences|January 1, 1991
Aging alters the force-frequency relationship and toxicity of oxidative stress in rabbit heartB J Cusack, P S Mushlin, T Andrejuk, et al.Pageof 5